BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 59.40
0.00 (0.00%)
Sep 9, 2026, 9:13 AM CST
BIONET Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,960 | 5,207 | 4,032 | 2,737 | 2,063 | 1,880 | |
Market Cap Growth | -29.11% | 29.12% | 47.30% | 32.70% | 9.73% | -2.06% |
Enterprise Value | 2,614 | 4,788 | 3,681 | 2,495 | 1,909 | 1,723 |
Last Close Price | 59.40 | 103.50 | 78.14 | 53.00 | 39.61 | 35.33 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 52.20 | 101.25 | 48.18 | 34.92 | 54.33 | 70.61 |
Forward PE | - | 235.01 | 235.01 | 235.01 | 235.01 | 235.01 |
PS Ratio | 2.29 | 4.21 | 3.30 | 2.43 | 2.10 | 2.04 |
PB Ratio | 1.34 | 2.31 | 1.68 | 1.59 | 1.56 | 1.43 |
P/TBV Ratio | 2.47 | 4.20 | 3.09 | 2.37 | 1.97 | 1.78 |
P/FCF Ratio | 38.54 | 213.22 | 53.66 | 20.58 | 31.36 | 507.15 |
P/OCF Ratio | 17.50 | 35.17 | 22.85 | 17.88 | 21.80 | 135.47 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.02 | 3.87 | 3.01 | 2.21 | 1.95 | 1.87 |
EV/EBITDA Ratio | 51.72 | 176.50 | 41.04 | 22.87 | 22.88 | 31.24 |
EV/EBIT Ratio | - | - | 59.00 | 29.45 | 33.59 | 55.22 |
EV/FCF Ratio | 34.03 | 196.06 | 48.99 | 18.75 | 29.02 | 464.92 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.06 | 0.05 | 0.04 | 0.03 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 2.78 | 2.80 | 0.94 | 0.37 | 0.14 | 0.21 |
Debt / FCF Ratio | 1.83 | 4.66 | 1.25 | 0.32 | 0.20 | 3.60 |
Net Debt / Equity Ratio | -0.60 | -0.57 | -0.62 | -0.50 | -0.32 | -0.28 |
Net Debt / EBITDA Ratio | -36.26 | -47.36 | -16.50 | -7.91 | -5.08 | -6.69 |
Net Debt / FCF Ratio | -17.18 | -52.61 | -19.70 | -6.48 | -6.44 | -99.64 |
Asset Turnover | 0.42 | 0.40 | 0.44 | 0.54 | 0.54 | 0.52 |
Inventory Turnover | 5.68 | 5.34 | 7.84 | 9.57 | 6.95 | 5.24 |
Quick Ratio | 3.93 | 4.21 | 4.77 | 3.67 | 2.77 | 2.34 |
Current Ratio | 4.27 | 4.62 | 5.06 | 3.90 | 3.06 | 2.77 |
Return on Equity (ROE) | 0.38% | 0.04% | 3.39% | 5.34% | 4.06% | 2.51% |
Return on Assets (ROA) | -0.32% | -0.29% | 1.42% | 2.53% | 1.96% | 1.11% |
Return on Invested Capital (ROIC) | -0.70% | -0.07% | 4.80% | 7.31% | 4.68% | 2.66% |
Return on Capital Employed (ROCE) | -0.60% | -0.50% | 2.30% | 4.20% | 3.60% | 2.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.93% | 0.99% | 2.08% | 2.86% | 1.84% | 1.42% |
FCF Yield | 2.59% | 0.47% | 1.86% | 4.86% | 3.19% | 0.20% |
Dividend Yield | 1.44% | 0.84% | 1.80% | 1.25% | 1.65% | 1.27% |
Payout Ratio | 122.54% | 136.24% | 39.61% | 41.62% | 61.93% | 32.94% |
Buyback Yield / Dilution | 0.97% | 0.56% | -0.33% | 0.16% | 0.53% | -0.14% |
Total Shareholder Return | 2.42% | 1.40% | 1.47% | 1.41% | 2.19% | 1.13% |